|
|
|
Real Estate News Releases
|
(EMAILWIRE.COM, October 19, 2011 ) Chicago, Illinois -- Shares of TranS1 Inc. (NasdaqGM: TSON) closed down 40.71% on Tuesday, after TranS1 Inc. (TSON) announced that they had received a subpoena from the U.S. Department of Health and Human Services.
TranS1 Inc. (TSON) is a medical device company, that focuses on the design, development, and marketing of products that implement its proprietary surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine.
The Stockfather publishes a stock alert newsletter to subscribers at http://www.thestockfather.com.
TranS1 Inc. (TSON) has a float of under 18 million shares and cash on hand of 32.09 million.
About The Stockfather:
The Stockfather searches the markets (from OTC to NYSE) for stocks positioned to make big gains. Stocks and companies are featured on the The Stockfather web site and e-newsletter.
Disclaimer:
For this particular news release, The Stockfather was not paid to profile the company(ies) or stock(s) mentioned. The Stockfather is not a registered investment advisor. Investors are responsible for doing their own research and obtaining professional investment advice. Investors should visit www.thestockfather.com for further disclosure information.
The Stockfather
David Conway
312-473-5916
alerts@thestockfather.com 
|
|
|
|
Real Estate News by Sector
|
|
|
|
|
